close

2.1_about-prolia_fracture-trial_chart12.2_about-prolia_extension-study_chart12.4_about-prolia_moa_chart1302612612_6404238834eb637de5eeca2009134912bb15489626444ea6e62ed40751

defaultimagesprolia 3prolia 5Prolia pre-filled syringe 60 mg_mLd35048de-8812-4dcf-9c96-a08600d5e04aprolia-8PTDC0104Slide1

Prolia®：Denosumab，the first FDA-approved RANK Ligand inhibitor

Prolia® targets and binds to RANK Ligand, inhibiting osteoclast formation, function and survival.

Thus, Prolia® can help keep osteoclasts from resorbing bone.

 

arrow
arrow
    全站熱搜

    Charlie 發表在 痞客邦 留言(0) 人氣()

    E-mail轉寄